Literature DB >> 9051375

NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance.

L M Hunt1, M A Valenzuela, J A Pugh.   

Abstract

OBJECTIVE: This study examines NIDDM patients' attitudes toward insulin injections, the basis of these attitudes, and how they may affect patients' willingness to take insulin. RESEARCH DESIGN AND METHODS: Forty-four low-income Mexican American NIDDM patients were interviewed using open-ended in-depth interviewing techniques. Transcripts were analyzed using techniques of content analysis. Data classification was cross-checked in analysis conferences and through a second researcher coding 50% of the cases, comparing the results, then resolving any discrepancies.
RESULTS: Patients' positive attitudes toward insulin focus on its efficacy and efficiency, the avoidance of complications, and feeling better and more energetic. Negative attitudes were much more frequently discussed and include "technical concerns": anxiety about the pain, proper techniques, and general hassles of taking injections; about hypoglycemic symptoms; and about insulin causing serious health problems; and "experimental concerns": sensing that the disease has progressed into a serious phase, that past treatment efforts have failed, and that the patient has not taken proper care. Attitudes were based on personal experience, observation, what others say, and interactions with health care professionals.
CONCLUSIONS: Results from the few published reports on NIDDM patients' attitudes about insulin from various cultural settings were consistent with our findings, indicating that these themes may be generally applicable to a wider population. It is recommended that health care providers take care to avoid unwitting promotion of negative attitudes toward insulin and actively elicit and respond to patient attitudes to reduce reluctance to take the medication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9051375     DOI: 10.2337/diacare.20.3.292

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  59 in total

1.  Characterization of proliferative effects of insulin, insulin analogues and insulin-like growth factor-1 (IGF-1) in human lung fibroblasts.

Authors:  M Warnken; U Reitzenstein; A Sommer; M Fuhrmann; P Mayer; H Enzmann; U R Juergens; K Racké
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-10-06       Impact factor: 3.000

2.  FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1 U), medium- (40 U), and high- (80 U) dose settings.

Authors:  Jakob Oest Wielandt; Marcus Niemeyer; Marianne Rye Hansen; Ditlef Bucher; Niels Bjerrum Thomsen
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

3.  Impact of a modified needle tip geometry on penetration force as well as acceptability, preference, and perceived pain in subjects with diabetes.

Authors:  Laurence Hirsch; Michael Gibney; Julie Berube; John Manocchio
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

Review 4.  The new diabetes inhalers: new tools for the clinician.

Authors:  William T Cefalu
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

5.  Selection and education of patients for inhaled insulin.

Authors:  Srikanth Bellary; Anthony H Barnett
Journal:  Curr Diab Rep       Date:  2007-10       Impact factor: 4.810

Review 6.  Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research.

Authors:  Michele Heisler
Journal:  Fam Pract       Date:  2009-03-17       Impact factor: 2.267

7.  Comparison of the dose accuracy of prefilled insulin pens.

Authors:  Alexander Weise; Johannes W Pfützner; Julia Borig; Anna M Pfützner; Michael Safinowski; Heike Hänel; Petra B Musholt; Andreas Pfützner
Journal:  J Diabetes Sci Technol       Date:  2009-01

Review 8.  Insulin analogs: impact on treatment success, satisfaction, quality of life, and adherence.

Authors:  Israel Hartman
Journal:  Clin Med Res       Date:  2008-09-18

9.  Pushing the envelope for cultural appropriateness: does evidence support cultural tailoring in type 2 diabetes interventions for Mexican American adults?

Authors:  Rachel E Davis; Karen E Peterson; Steven K Rothschild; Ken Resnicow
Journal:  Diabetes Educ       Date:  2011-02-22       Impact factor: 2.140

10.  Psychological insulin resistance among low-income, U.S. racial minority patients with type 2 diabetes.

Authors:  Suman Machinani; Shahrzad Bazargan-Hejazi; Stanley H Hsia
Journal:  Prim Care Diabetes       Date:  2012-12-17       Impact factor: 2.459

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.